These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5677962)

  • 1. Hypolipidemic effect of polyvinylpyrrolidone in man.
    Sanbar SS; Smet G
    Circulation; 1968 Oct; 38(4):771-6. PubMed ID: 5677962
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of hyperlipoproteinemia to cholestyramine resin.
    Fallon HJ; Woods JW
    JAMA; 1968 Jun; 204(13):1161-4. PubMed ID: 5694692
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of high molecular weight dextran on experimental hypercholesterolemia.
    Brahmankar DM; Connor WE
    Circ Res; 1967 Dec; 21(6):817-21. PubMed ID: 6078143
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of dextran on plasma lipids. A study on patient with essential hypercholesterolemia or hyperlipemia.
    Blohmé G; Kerstell J; Svanborg A
    Acta Med Scand; 1968 May; 183(5):481-5. PubMed ID: 5703642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of hydroxyethyl starch on blood volume and extracellular fluid volume during hemorrhage--comparison with the effect of clinical dextran and re-infusion of autologous blood].
    Ikeda K; Tanaka S; Mizutani H; Horii D; Arai Y
    Masui; 1971 Jul; 20(7):639-47. PubMed ID: 5105401
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
    Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of dextran, polyvinylpyrrolidone, and isotonic saline infusion in the human.
    ARMSTRONG JB; DOWNEY JA; FERGUSON MH; WILLIAMS HR
    Can J Biochem Physiol; 1954 Nov; 32(6):636-43. PubMed ID: 13209402
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    Mann JI; Harding PA; Turner RC; Wilkinson RH
    Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood volume and plasma protein. V. Changes in blood volume and plasma proteins on administration of different substitutes after operations in man.
    Kaijser L; Rieger A
    Acta Chir Scand; 1968; 134(1):15-26. PubMed ID: 4876958
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic effects of the bile acid sequestrant polidexide (SecholexR) in man.
    Simons LA; Myant NB
    Adv Exp Med Biol; 1977; 82():188-90. PubMed ID: 200089
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholestyramine as a cholesterol lowering preparation. A clinical evaluation].
    Bye A; Brox D
    Tidsskr Nor Laegeforen; 1976 Jun; 96(16):928-9. PubMed ID: 779134
    [No Abstract]   [Full Text] [Related]  

  • 14. [Animal experimental studies on the effect of colloidal plasma substitutes in canine hemorrhagic shock].
    Lutz H
    Z Gesamte Exp Med Einschl Exp Chir; 1968 Apr; 146(4):383-96. PubMed ID: 5671891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Volume therapy in shock].
    Gruber UF; Rittmann WW
    Verh Dtsch Ges Inn Med; 1971; 77():1243-9. PubMed ID: 4949694
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of clinical and biological effects of an intravenous perfusion of a sodium balanced colloidal solution in man].
    Chapman A; Willemin F; Puech MH; Bruniaux J; Vourc'h G
    Anesth Analg (Paris); 1971; 28(6):1065-91. PubMed ID: 5154082
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy.
    Casdorph HR
    Angiology; 1970 Nov; 21(10):654-60. PubMed ID: 5480092
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood, blood components, plasma expander. 37].
    Jacker HJ
    Pharm Prax; 1969; 7():160-6. PubMed ID: 4185730
    [No Abstract]   [Full Text] [Related]  

  • 19. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK
    JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412
    [No Abstract]   [Full Text] [Related]  

  • 20. High fiber diet in hyperlipemia. Comparison with cholestyramine treatment in type IIA hyperlipoproteinemia.
    Palumbo PJ; Briones ER; Nelson RA
    JAMA; 1978 Jul; 240(3):223-7. PubMed ID: 660847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.